Related Articles
DCF intraperitoneal and intravenous dual chemotherapy regimen for advanced gastric cancer: A feasibility study
Docetaxel combined with intraperitoneal hyperthermic perfusion chemotherapy and hyperthermia in the treatment of advanced ovarian cancer
Prospective comparison of the value of CRASH and CARG toxicity scores in predicting chemotherapy toxicity in geriatric oncology
Erlotinib as second‑ or third‑line treatment in elderly patients with advanced non‑small cell lung cancer: Keio Lung Oncology Group Study 001 (KLOG001)
COMPARISON OF RESPONSE TO 5'-DEOXY-5-FLUOROURIDINE THERAPY ALONE AND IN COMBINATION WITH TAMOXIFEN OR MEDROXYPROGESTERONE ACETATE IN ADVANCED AND RECURRENT BREAST-CANCER